Paeds Cases · allergy-and-immunology
Explaining SCID and the transplant urgency — OSCE
Communication and structured-discussion OSCE on explaining to the parents of a six-week-old boy — referred after a low TREC newborn screen and confirmed to have X-linked SCID on flow cytometry and genetic testing — what SCID is, why it is a medical emergency, what the live-vaccine and blood-product rules mean, what the transplant involves and why it must happen before infection, and what the genetic implications are for the family, including the mother's anxiety about her son surviving and the father's belief that the family history is irrelevant.
On this page & tools
Target exams
Candidate instructions (8-minute station)
You are the paediatric registrar in the clinic. A six-week-old boy has been referred because his newborn screening dried blood spot returned a low T-cell receptor excision circle (TREC) result. Flow cytometry confirmed a T⁻B⁺NK⁻ pattern and genetic testing confirmed an IL2RG mutation — X-linked severe combined immunodeficiency (SCID). He is clinically well and feeding normally. [1]
Your tasks are: [2]
- Explain to the parents what SCID is and why it is a medical emergency, in language they can understand. [2]
- Explain the protections you are putting in place — no live vaccines, irradiated blood products, prophylaxis, immunoglobulin — and why they matter. [9]
- Explain the transplant and why it must happen before infection, and what the expected outcome is. [2]
- Address the mother's fear that her son will die and the father's belief that the family history is just coincidence. [1]
You are not expected to organise the donor search or the conditioning regimen in the station, but you should name them as the next steps and explain what they involve. [10]
Examiner prompt to the actors (parents)
Mother: "I looked it up online and it said babies with this die before they're two. Is my son going to die? What can you actually do for him?" [2]
Father: "His uncle died forty years ago. Medicine has moved on since then, surely. And anyway, that was on her side of the family — it's got nothing to do with my genes. Why are you even talking about our future children?" [1]
Marking domains
- Frame and honesty (3): sets a calm, honest tone; explains that SCID is serious but treatable; acknowledges the parents' fear without dismissing it; frames the conversation as "we have caught this early, and that changes everything," while being truthful about the urgency. [2]
- Explaining SCID and the protections (3): explains that the baby's immune system is missing its T cells, the cells that direct the whole immune response; explains the four protections — no live vaccines (they could make him seriously ill), irradiated blood (to prevent a dangerous reaction), antibiotics to prevent infection, and immunoglobulin (antibodies he cannot make himself) — in plain language. [9]
- The transplant and outcome (2): explains that the cure is a bone-marrow transplant from a healthy donor, that it works best when done before the baby gets any infection, and that because the newborn screen caught this early the chances of success are over 90 percent; names the next steps (finding a donor, the transplant centre referral) without overcomplicating. [2] [10]
- Communication and addressing the parents (2): addresses the mother's fear by being honest but hopeful — the baby was caught early, the outcome is good, and the team will move quickly; addresses the father's family-history belief by explaining that the condition is carried by the mother but affects sons, that the uncle's death was the same condition, and that future pregnancies can be tested so the same thing does not happen again. [1]
Model answer — the explanatory script
"Thank you both for coming in. I want to explain what we've found and what we're going to do about it, and I want you to ask me anything as we go. Your son is well right now — he's feeding and growing, and that's the best possible position to be in. What the newborn screening test found is that his immune system hasn't developed the way it should. It's a condition called severe combined immunodeficiency, or SCID, and the tests have confirmed it." [1]
"Let me explain what SCID means. Your son's immune system is missing a type of cell called a T cell. T cells are like the conductor of an orchestra — they tell all the other immune cells what to do. Without them, the whole immune system can't work properly, even the parts that are there. So your son can't fight off infections the way other babies can. The infections that a normal baby would shrug off — a chest infection, a tummy bug, a fungal infection in the mouth — could make him very seriously ill. That's why this is something we need to act on quickly." [2]
"Now, I know you've been reading about this, and I want to be honest with you. You're right that untreated SCID is a very serious condition. But here's the crucial thing — and this is the most important point of our whole conversation today. We found this early. Your son was picked up by the newborn screening test before he got sick. And that changes everything. Because the treatment for SCID is a bone-marrow transplant — we give him a new immune system from a healthy donor — and the transplant works best when it's done before the baby gets any infection. Your son is well, he's six weeks old, and we have a window to get this transplant done before he gets sick. In that window, the chances of success are over 90 percent. That's why I'm optimistic, and that's why we're going to move quickly." [2]
"Before the transplant, there are some rules we need to follow to keep him safe. These are non-negotiable, and I'll explain why each one matters. First, no live vaccines. You know how babies get the BCG and the rotavirus vaccine? Those are live vaccines — they're a weakened version of the germ, safe in a normal baby but dangerous in a baby whose immune system can't handle even a weakened germ. So we stop those. Second, if he ever needs a blood transfusion — and I hope he won't — the blood has to be specially treated. Normal blood contains immune cells that could attack him, so we use irradiated blood, which is perfectly safe for him. Third, he'll go on antibiotics to prevent a specific type of chest infection called Pneumocystis. And fourth, he'll have immunoglobulin — that's antibodies donated by healthy people — given through a drip every few weeks, to give him the protection his own immune system can't make." [9]
"The transplant itself — let me explain that in plain terms. We find a donor, ideally a brother or sister who's a match, but if not, we look on a registry or use one of you as a half-match. The donor's bone-marrow cells are given to your son through a drip, and those cells settle in his bones and grow into a new, working immune system. It's not surgery in the way you might think — there are no cuts. He'll need some chemotherapy beforehand to make space for the new cells, and he'll be in hospital for several weeks. But the outcome, when it's done before infection like we're planning, is excellent — over 90 percent of these children survive and go on to live normal lives." [2] [10]
"To your question about whether he's going to die — I understand that fear, and it's the right question to ask. The honest answer is that SCID is a serious condition, and I won't pretend it isn't. But we caught it early, he's well, and the treatment works. The children who do less well are the ones who aren't found until after they get a serious infection. Your son has been found before that, and that's the single biggest advantage he could have. So my honest expectation is that he will do well, but it will be a difficult few months while we get the transplant done." [2]
"And to your point about the family history — I'm really glad you raised it. The condition your son has is called X-linked SCID. What that means is that the gene change is carried by the mother — so it's on your side of the family, if I can put it that way — but it only affects boys. The uncle who died as a baby almost certainly had the same condition. Medicine has moved on enormously since then — forty years ago we couldn't test for this, we couldn't screen for it at birth, and the transplants were in their infancy. Now we can do all of those things, and that's why your son's outlook is so different. The reason I'm talking about future children is that because the gene change is carried by the mother, each future pregnancy has a chance of being affected — a one-in-two chance of a boy having the same condition. But we can test for it. We can test a baby during pregnancy, or even before pregnancy with IVF, so that we know whether the baby has the condition. And if we know, we can do exactly what we're doing for your son — catch it early, and treat it before infection. So the family history isn't a coincidence — it's the key to understanding this, and it's the reason we can make sure the same thing doesn't happen again." [1]
"So to finish: your son has SCID, we caught it early, he's well, and the treatment — a bone-marrow transplant — has a success rate of over 90 percent when it's done before infection, which is exactly the position we're in. We're going to protect him with no live vaccines, irradiated blood, antibiotics, and immunoglobulin. We're going to find a donor and get him to a transplant centre quickly. And we're going to support you as a family, including testing for future pregnancies. Does that all make sense, and what questions do you have?" [2] [10]
References
- [1]Kwan A; Abraham RS; Currier R; Brower A; Andruszewski K; Abbott JK; Baker M; Ballow M Newborn screening for severe combined immunodeficiency in 11 screening programs in the United States. JAMA, 2014.PMID 25138334
- [2]Pai SY; Logan BR; Griffith LM; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Hanson IC Transplantation outcomes for severe combined immunodeficiency, 2000-2009. N Engl J Med, 2014.PMID 25075835
- [9]Medical Advisory Committee of the Immune Deficiency Foundation; Shearer WT; Fleisher TA; Buckley RH; Ballas Z; Ballow M Recommendations for live viral and bacterial vaccines in immunodeficient patients and their close contacts. J Allergy Clin Immunol, 2014.PMID 24582311
- [10]Lankester AC; Neven B; Mahlaoui N; von Asmuth EGJ; Courteille V; Alligon M Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohort. J Allergy Clin Immunol, 2022.PMID 34718043